iCareDx

Acuamark Diagnostics is a molecular diagnostics company based in New York, NY, dedicated to revolutionizing primary care by making early cancer detection the new standard. Their innovative technology allows for highly accurate screening of blood to detect cancer markers at the early stages, ensuring timely intervention and treatment.

With a mission to unlock frequent, recurring monitoring for early cancer signals, Acuamark Diagnostics aims to provide a more accurate, reliable, cost-effective, and scalable solution that can have a significant societal impact. Their team of experts, including Dr. Giulia Kennedy, brings decades of experience in developing novel diagnostic technologies, positioning Acuamark Diagnostics as a potential game changer in the field of liquid biopsy and cancer detection.

Generated from the website